UBS lowered the firm’s price target on Match Group to $36 from $40 and keeps a Neutral rating on the shares. While UBS continues to model Tinder Payers to return to quarter over quarter growth in Q3, UBS also continues to assume Tinder Q4 year over year Payer growth remains negative as visibility into the benefit of product initiatives appears limited, the analyst tells investors in a research note.